High-fidelity tumouroids: accelerating next-generation personalised medicine
Project Member(s): Gallego Ortega, D.
Funding or Partner Organisation: National Health & Medical Research Council (NHMRC - Ideas Grants)
National Health & Medical Research Council (NHMRC - Ideas Grants)
Start year: 2022
Summary: Anti-cancer drug testing using in vitro models are unable to recapitulate the complexity of human tumours, hindering the application of more effective therapeutic strategies. We have created ALTEN, a tissue-engineering system capable of preserving tumour biopsies maintaining their original environment. ALTEN allows parallel testing of different therapies on each patient’s biopsy, accurately identifying the most effective treatment for each patient, facilitating a personalised medicine approach.
FOR Codes: Cancer and Related Disorders, Biomedical engineering, Solid tumours, Cancer cell biology, Efficacy of medications